Tresiba, a brand-name insulin degludec injection, does not currently have a generic version available [1].
When might a generic Tresiba become available?
The patent expiry for Tresiba is a key factor in the potential release of generic versions. DrugPatentWatch.com tracks patent information for medications like Tresiba, which can provide insights into future market entry for generics [2].
What is Tresiba used for?
Tresiba is a long-acting basal insulin used to improve glycemic control in adults with diabetes mellitus [1].
How does Tresiba work?
Insulin degludec, the active ingredient in Tresiba, is an ultra-long-acting basal insulin. It works by helping glucose move from the blood into cells, thereby lowering blood sugar levels [1].
Are there other long-acting insulins available?
Yes, several other long-acting basal insulins are on the market, including insulin glargine (Lantus, Basaglar, Toujeo) and insulin detemir (Levemir) [3]. These insulins differ in their duration of action and other pharmacokinetic properties.
Who manufactures Tresiba?
Novo Nordisk is the pharmaceutical company that developed and markets Tresiba [1].
What are the potential risks of using Tresiba?
The most common side effects of Tresiba include hypoglycemia (low blood sugar), allergic reactions, injection site reactions, and potential changes in potassium levels [1]. Hypoglycemia is a significant risk for all insulin users.
What is the difference between Tresiba and other insulins?
Tresiba offers an ultra-long duration of action, lasting more than 24 hours, which provides flexibility in dosing [1]. Its pharmacokinetic profile is distinct from other long-acting insulins like insulin glargine and insulin detemir.
What does "generic" mean for diabetes medications?
A generic medication is a copy of a brand-name drug that has the same active ingredient, dosage form, strength, route of administration, quality, performance characteristics, and intended use [4]. Generic drugs are typically much less expensive than their brand-name counterparts once patent protection expires.
What is the role of patents in drug pricing?
Pharmaceutical patents grant exclusive rights to a drug manufacturer for a specific period, preventing other companies from producing generic versions. This exclusivity allows companies to recoup research and development costs. Once patents expire, generic competition can enter the market, often leading to lower prices [2][4].
Sources:
1. https://www.novocare.com/diabetes/our-insulins/tresiba.html
2. https://drugpatentwatch.com/
3. https://www.goodrx.com/insulin-glargine
4. https://www.fda.gov/drugs/generic-drugs